.

LPL - PSC LORDS FAVOUR

SHOP NO. 2, MAKKI MASJID, BEHIND LNJP H
OSPITAL, DELHI - 110002
DELHI

Name : Mrs. POOJA AGARWAL Collected : 9/4/2018 11:58:00AM

Received : 9/4/2018 12:00:08PM
Lab No. : 134846339 Age: 40 Years Gender: Female Reported : 9/4/2018 6:48:44PM
A/c Status : P Ref By : Dr.JAYSHREE SUNDAR Report Status : Interim

Test Name Results Units Bio. Ref. Interval

ANTENATAL PANEL 1

SUGAR CHOICE
(Hexokinase)

Glucose, Fasting 85.00 mg/dL 70.00 - 100.00

PatientReportSCSuperPanel.GENERAL_PANEL_ANALYTE_SC (Version: 6)

*134846339* Page 1 of 11
.

LPL - PSC LORDS FAVOUR

SHOP NO. 2, MAKKI MASJID, BEHIND LNJP H
OSPITAL, DELHI - 110002
DELHI

Name : Mrs. POOJA AGARWAL Collected : 9/4/2018 11:58:00AM

Received : 9/4/2018 12:00:08PM
Lab No. : 134846339 Age: 40 Years Gender: Female Reported : 9/4/2018 6:48:46PM
A/c Status : P Ref By : Dr.JAYSHREE SUNDAR Report Status : Interim

Test Name Results Units Bio. Ref. Interval

COMPLETE BLOOD COUNT (CBC)

(Electrical Impedance & VCS,Photometry )

Hemoglobin 8.90 g/dL 11.50 - 15.00

Packed Cell Volume (PCV) 31.40 % 36.00 - 46.00
RBC Count 4.61 mill/mm3 3.80 - 4.80
MCV 68.10 fL 80.00 - 100.00
MCH 19.30 pg 27.00 - 32.00
MCHC 28.30 g/dL 32.00 - 35.00
Red Cell Distribution Width (RDW) 21.90 % 11.50 - 14.50
Total Leukocyte Count (TLC) 6.99 thou/mm3 4.00 - 10.00
Differential Leucocyte Count (DLC)

Segmented Neutrophils 61.40 % 40.00 - 80.00

Lymphocytes 29.50 % 20.00 - 40.00

Monocytes 7.40 % 2.00 - 10.00

Eosinophils 1.00 % 1.00 - 6.00

Basophils 0.70 % <2.00

Absolute Leucocyte Count

Neutrophils 4.29 thou/mm3 2.00 - 7.00

Lymphocytes 2.06 thou/mm3 1.00 - 3.00
Monocytes 0.52 thou/mm3 0.20 - 1.00
Eosinophils 0.07 thou/mm3 0.02 - 0.50

Basophils 0.05 thou/mm3 0.01 - 0.10

Platelet Count 332.0 thou/mm3 150.00 - 450.00
Note
1. As per the recommendation of International council for Standardization in Hematology, the differential
leucocyte counts are additionally being reported as absolute numbers of each cell in per unit volume of
blood

2. Test conducted on EDTA whole blood

*134846339* Page 2 of 11
.

LPL - PSC LORDS FAVOUR

SHOP NO. 2, MAKKI MASJID, BEHIND LNJP H
OSPITAL, DELHI - 110002
DELHI

Name : Mrs. POOJA AGARWAL Collected : 9/4/2018 11:58:00AM

Received : 9/4/2018 12:00:08PM
Lab No. : 134846339 Age: 40 Years Gender: Female Reported : 9/4/2018 6:48:48PM
A/c Status : P Ref By : Dr.JAYSHREE SUNDAR Report Status : Interim

Test Name Results Units Bio. Ref. Interval

HIV 1 & 2 ANTIBODIES SCREENING TEST, SERUM

-------------------------------
| Final Result : Negative |
-------------------------------

HIV 1 / 2 & P 24 COMBO TEST

(CMIA)
Index Value 0.17
Result Non Reactive

Interpretation
--------------------------------------------------------
| RESULT IN INDEX | REMARKS |
|------------------------|-------------------------------|
| < 1.00 | Non Reactive |
|------------------------|-------------------------------|
| >= 1.00 | Provisionally Reactive |
--------------------------------------------------------

Comments
Negative result implies that antibodies to HIV 1 / 2 have not been detected in the sample.This means the
patient has either not been exposed to HIV 1 / 2 infection or the sample has been tested during the "window
phase" i.e. before the development of detectable levelsof antibodies. Hence a Negative result does not
exclude the possibility of exposure or infection with HIV 1 / 2.

Recommendations
1. Results to be clinically correlated.
2. Rarely false negativity/positivity may occur.
3. Post test counseling available between 9.00 am to 5:00 pm at LPL laboratories.

PatientReportSCSuperPanel.HIV_SC (Version: 6)

*134846339* Page 3 of 11
.

LPL - PSC LORDS FAVOUR

SHOP NO. 2, MAKKI MASJID, BEHIND LNJP H
OSPITAL, DELHI - 110002
DELHI

Name : Mrs. POOJA AGARWAL Collected : 9/4/2018 11:58:00AM

Received : 9/4/2018 12:00:08PM
Lab No. : 134846339 Age: 40 Years Gender: Female Reported : 9/4/2018 6:48:49PM
A/c Status : P Ref By : Dr.JAYSHREE SUNDAR Report Status : Interim

Test Name Results Units Bio. Ref. Interval

VDRL (RPR), SERUM Non Reactive
(Slide flocculation)

Note: Titers of 1: 8 and above are significant

Comments
This is a screening test for syphilis which is useful for following the progression of disease and response to
therapy. Rising titers are of immense value in confirming the diagnosis. Biological false positive reactions
exhibit low titers and are seen in conditions like Viral fevers, Mycoplasma infection, Chlamydia infection,
Malaria, Immunizations, Pregnancy, Autoimmune disorders & past history of Treponemal infection. It is
advisable to confirm the diagnosis by tests such as TPHA & FTA-ABS.

BLOOD GROUP, ABO & RH TYPING

(Erythrocyte Magnetized Technology)

ABO Group AB

Rh Factor Positive

Note: 1. Both forward and reverse grouping performed

2. Test conducted on EDTA whole blood
HEPATITIS B SURFACE ANTIGEN;HBsAg, SERUM Non Reactive Non Reactive
(CMIA)

Note
1. All Reactive results are tested additionally by Specific antibody Neutralization assay . For further
confirmation Molecular assays are recommended
2. Discrepant results may be observed during pregnancy, patients receiving mouse monoclonal
antibodies for diagnosis or therapy & mutant forms of HBsAg
3. For diagnostic purposes, results should be used in conjunction with clinical history and other hepatitis
markers for Acute or Chronic infection
4. For monitoring HBsAg levels, Quantitative HBsAg assay is recommended

Comment
Hepatitis B Virus ( HBV) is a member of the Hepadna virus family causing infections of the liver with
extremely variable clinical features. Hepatitis B is transmitted primarily by body fluids especially serum and
also spread effectively sexually and from mother to baby. In most individuals HBV hepatitis is self limiting, but
1-2% normal adolescents and adults develop Chronic Hepatitis. Frequency of chronic HBV infection is
PatientReportSCSuperPanel.SP_GENERAL_TEMPLATE01_SC (Version: 7)

*134846339* Page 4 of 11
.

LPL - PSC LORDS FAVOUR

SHOP NO. 2, MAKKI MASJID, BEHIND LNJP H
OSPITAL, DELHI - 110002
DELHI

Name : Mrs. POOJA AGARWAL Collected : 9/4/2018 11:58:00AM

Received : 9/4/2018 12:00:08PM
Lab No. : 134846339 Age: 40 Years Gender: Female Reported : 9/4/2018 6:48:49PM
A/c Status : P Ref By : Dr.JAYSHREE SUNDAR Report Status : Interim

Test Name Results Units Bio. Ref. Interval

5-10% in immunocompromised patients and 80% in neonates. The initial serological marker of acute
infection is HBsAg which typically appears 2-3 months after infection and disappears 12-20 weeks after onset
of symptoms. Persistence of HBsAg for more than six months indicates development of carrier state or
Chronic liver disease.
Uses
· Routine screening of blood and blood products to prevent transmission of Hepatitis B virus (HBV) to
recipients
· To diagnose suspected HBV infection and monitor the status of infected individuals
· To evaluate the efficacy of antiviral drugs
· For Prenatal Screening of pregnant women

PatientReportSCSuperPanel.SP_GENERAL_TEMPLATE01_SC (Version: 7)

*134846339* Page 5 of 11
.

LPL - PSC LORDS FAVOUR

SHOP NO. 2, MAKKI MASJID, BEHIND LNJP H
OSPITAL, DELHI - 110002
DELHI

Name : Mrs. POOJA AGARWAL Collected : 9/4/2018 11:58:00AM

Received : 9/4/2018 12:00:08PM
Lab No. : 134846339 Age: 40 Years Gender: Female Reported : 9/4/2018 6:48:51PM
A/c Status : P Ref By : Dr.JAYSHREE SUNDAR Report Status : Interim

Test Name Results Units Bio. Ref. Interval

URINE EXAMINATION, ROUTINE; URINE, R/E
(Automated Strip Test, Microscopy)

Physical

Colour Light Yellow Pale yellow

Specific Gravity <=1.005 1.001 - 1.030

pH 7 5.0 - 8.0

Chemical

Proteins Nil Nil

Glucose Nil Nil

Ketones Nil Nil

Bilirubin Nil Nil

Urobilinogen Normal Normal

Leucocyte Esterase Negative Negative

Nitrite Negative Negative

Microscopy

R.B.C. Negative Negative

Pus Cells Negative 0-5 WBC / hpf

Epithelial Cells Few Few

Casts Nil Nil /lpf

Crystals Nil Nil

Others Nil -

PatientReportSCSuperPanel.URINE_EXAMINATION_SC (Version: 6)

*134846339*
Page 6 of 11
.

LPL - PSC LORDS FAVOUR

SHOP NO. 2, MAKKI MASJID, BEHIND LNJP H
OSPITAL, DELHI - 110002
DELHI

Name : Mrs. POOJA AGARWAL Collected : 9/4/2018 11:58:00AM

Received : 9/4/2018 12:00:08PM
Lab No. : 134846339 Age: 40 Years Gender: Female Reported : 9/4/2018 6:48:53PM
A/c Status : P Ref By : Dr.JAYSHREE SUNDAR Report Status : Interim

Test Name Results Units Bio. Ref. Interval

HEPATITIS C ANTIBODY (Anti-HCV), SERUM 0.05 Index <1.00
(CMIA)

Interpretation
-----------------------------------------
| RESULT (INDEX) | REMARKS |
|-----------------|-----------------------|
| <1.00 | Non Reactive / |
| | Not Detected |
| | |
|-----------------|-----------------------|
| >=1.00 | Reactive/Asymptomatic/|
| | Infective state/ |
| | Carrier state |
-----------------------------------------
Note
1. False positive results are seen in Autoimmune diseases, Rheumatoid factor,
Hypergammaglobulinemia, Paraproteinemia, passive antibody transfer, Anti- idiotypes & Anti
superoxide dismutase
2. Supplemental testing is necessary in Reactive results with index value between 1.0 - 5.0 to identify and
exclude biological false positive results
3. All reactive results should be verified by HCV RNA PCR to differentiate between past and present
infection (as per CDC recommendation)
4. False negative results are seen in early Acute infection, Immunosuppression &
Immuno-incompetence

Comments
Hepatitis C (HCV) is an RNA virus of Flavivirus group transmitted via blood transfusions, transplantation,
injection drug users, accidental needle punctures in healthcare workers, dialysis patients and rarely from
mother to infant.10% of new cases show sexual transmission. As compared to HAV & HBV, chronic infection
with HCV occurs in 85% of infected individuals. In high risk populations, the predictive value of Anti HCV for
HCV infection is > 99% whereas in low risk populations it is only 25%.

Uses
· Indicator of past or present infection, but does not differentiate between Acute / Chronic / Resolved
infection
· Routine screening of low and high prevalence populations including blood donors

PatientReportSCSuperPanel.SP_GENERAL_TEMPLATE01_SC (Version: 7)

*134846339* Page 7 of 11
.

LPL - PSC LORDS FAVOUR

SHOP NO. 2, MAKKI MASJID, BEHIND LNJP H
OSPITAL, DELHI - 110002
DELHI

Name : Mrs. POOJA AGARWAL Collected : 9/4/2018 11:58:00AM

Received : 9/4/2018 12:00:08PM
Lab No. : 134846339 Age: 40 Years Gender: Female Reported : 9/4/2018 6:48:53PM
A/c Status : P Ref By : Dr.JAYSHREE SUNDAR Report Status : Interim

Test Name Results Units Bio. Ref. Interval

IRON STUDIES, SERUM
(Spectrophotometry)

Iron 16.00 µg/dL 50.00 - 170.00

Total Iron Binding Capacity 491.00 µg/dL 250.00 - 425.00

Transferrin Saturation 3.26 % 15.00 - 50.00

Comments
Iron is an essential trace mineral element which forms an important component of hemoglobin,
metallocompounds and Vitamin A. Deficiency of iron, leads to microcytic hypochromic anemia. The toxic
effects of iron are deposition of iron in various organs of the body and hemochromatosis.
Total Iron Binding capacity (TIBC) is a direct measure of the protein Transferrin which transports iron from
the gut to storage sites in the bone marrow. In iron deficiency anemia, serum iron is reduced and TIBC
increases.
Transferrin Saturation occurs in Idiopathic hemochromatosis and Transfusional hemosiderosis where no
unsaturated iron binding capacity is available for iron mobilization. Similar condition is seen in congenital
deficiency of Transferrin.

THYROID PROFILE, FREE, SERUM

(CLIA)

T3, Free; FT3 2.97 pg/mL 2.30 - 4.20

T4, Free; FT4 1.22 ng/dL 0.89 - 1.76

TSH, Ultrasensitive 1.651 uIU/mL 0.550 - 4.780

Reference Ranges for pregnancy

-------------------------------------------------------------------------
| PREGNANCY | REFERENCE RANGE for TSH in | REFERENCE |REFERENCE |
| | uIU/mL (As per American | RANGE for FT3|RANGE for FT4 |
| | Thyroid Association) | in pg/mL |in ng/dL |
|-------------|----------------------------|--------------|---------------|
|1st Trimester| 0.100 - 2.500 | 2.11-3.83 |0.70 -2.00 |
|-------------|----------------------------|--------------|---------------|
|2st Trimester| 0.200 - 3.000 | 1.96-3.38 |0.50 -1.60 |
|-------------|----------------------------|--------------|---------------|
|3st Trimester| 0.300 - 3.000 | 1.96-3.38 |0.50 -1.60 |
--------------------------------------------------------------------------

Note
PatientReportSCSuperPanel.SP_GENERAL_TEMPLATE01_SC (Version: 7)

*134846339* Page 8 of 11
.

LPL - PSC LORDS FAVOUR

SHOP NO. 2, MAKKI MASJID, BEHIND LNJP H
OSPITAL, DELHI - 110002
DELHI

Name : Mrs. POOJA AGARWAL Collected : 9/4/2018 11:58:00AM

Received : 9/4/2018 12:00:08PM
Lab No. : 134846339 Age: 40 Years Gender: Female Reported : 9/4/2018 6:48:53PM
A/c Status : P Ref By : Dr.JAYSHREE SUNDAR Report Status : Interim

Test Name Results Units Bio. Ref. Interval

1. TSH levels are subject to circadian variation, reaching peak levels between 2 - 4.a.m. and at a
minimum between 6-10 pm. The variation is of the order of 50%. hence time of the day has influence
on the measured serum TSH concentrations.

2. TSH Values <0.03 uIU/mL need to be clinically correlated due to presence of a rare TSH variant in
some individuals

Clinical Use
· Primary Hypothyroidism
· Hyperthyroidism
· Hypothalamic - Pituitary hypothyroidism
· Inappropriate TSH secretion
· Nonthyroidal illness
· Autoimmune thyroid disease
· Pregnancy associated thyroid disorders
· Thyroid dysfunction in infancy and early childhood

PatientReportSCSuperPanel.SP_GENERAL_TEMPLATE01_SC (Version: 7)

*134846339* Page 9 of 11
.

LPL - PSC LORDS FAVOUR

SHOP NO. 2, MAKKI MASJID, BEHIND LNJP H
OSPITAL, DELHI - 110002
DELHI

Name : Mrs. POOJA AGARWAL Collected : 9/4/2018 11:58:00AM

Received : 9/4/2018 12:00:08PM
Lab No. : 134846339 Age: 40 Years Gender: Female Reported : 9/4/2018 6:48:55PM
A/c Status : P Ref By : Dr.JAYSHREE SUNDAR Report Status : Interim

Test Name Results Units Bio. Ref. Interval

RUBELLA ANTIBODIES PANEL, IgG & IgM, SERUM

(CLIA)
Rubella IgG 242.00 IU/mL <10.00
Rubella IgM <10.0 AU/mL <20.00

Interpretation
------------------------------------------------------------------------
| RUBELLA IgG RESULT IN IU/mL| RUBELLA IgM RESULT IN AU/mL| REMARKS |
|----------------------------|----------------------------|--------------|
| <10.00 | <20.00 | Non Reactive |
|----------------------------|----------------------------|--------------|
| - | 20.00-25.00 | Equivocal |
|----------------------------|----------------------------|--------------|
| >10.00 | >25.00 | Reactive |
------------------------------------------------------------------------

Note
1. Equivocal results should be retested after 2-4 weeks.
2. Reactive IgM antibody may indicate current infection, re-infection or recent vaccination
To differentiate between current and re-infection, IgG avidity test is recommended.
High avidity index is suggestive of re-infection.
3. IgM Rheumatoid factor in combination with Rubella IgG can lead to false reactive Rubella IgM
results.
4. Anomalous results may occur due to the presence of heterophilic antibodies in human serum or in
patients who have received mouse monoclonal antibodies for diagnosis or therapy.
5. All results should be interpreted by the physician with other clinical findings and diagnostic information.

Comments
Primary post natal Rubella virus infection is typically a self limiting mild disease . In utero infection with Rubella
IgM may severely damage the fetus . Primary prenatal infections may have devastating effects leading to
Congenital Rubella Syndrome (CRS) in the neonates. This syndrome includes low birth weight, cataract,
deafness, congenital heart disease and mental retardation.
A positive Rubella IgG antibody indicates successful immunization or past exposure. The result of a single
antibody determination should not be used to diagnose recent infection. Acute and convalescent sera should
be collected 2-4 weeks apart and a rising titer of more than 30% is considered significant.
In case of acute primary infection, IgM has been detected 4-15 days after the appearance of rash. The levels
begin to decline after 36-70 days but infrequently may be detected upto 180 days. In suspected cases of
primary infection, the optimum time of specimen collection is 1-2 weeks after the onset of rash.

PatientReportSCSuperPanel.GENERAL_PANEL_ANALYTE_SC (Version: 6)

*134846339* Page 10 of 11
.

LPL - PSC LORDS FAVOUR

SHOP NO. 2, MAKKI MASJID, BEHIND LNJP H
OSPITAL, DELHI - 110002
DELHI

Name : Mrs. POOJA AGARWAL Collected : 9/4/2018 11:58:00AM

Received : 9/4/2018 12:00:08PM
Lab No. : 134846339 Age: 40 Years Gender: Female Reported : 9/4/2018 6:48:55PM
A/c Status : P Ref By : Dr.JAYSHREE SUNDAR Report Status : Interim

Test Name Results Units Bio. Ref. Interval

Dr. Ritu Nayar Dr. Shalabh Malik Dr. Anil Arora Dr Himangshu Mazumdar
MD (Microbiology) MD (Microbiology) MD (Pathology) MD (Biochemistry)
Deputy HOD Microbiology & Serology - National Head - Microbiology & HOD Hemat & Imm - NRL Consultant Biochemist - NRL
NRL Serology - NRL

Dr. Nimmi Kansal

MD (Biochemistry)
HOD Biochem & IA - NRL

Result/s to follow:
HEMOGLOBIN HPLC/ELECTROPHORESIS, CULTURE, URINE

IMPORTANT INSTRUCTIONS

*Test results released pertain to the specimen submitted .*All test results are dependent on the quality of the sample received by the Laboratory .
*Laboratory investigations are only a tool to facilitate in arriving at a diagnosis and should be clinically correlated by the Referring Physician .*Sample
repeats are accepted on request of Referring Physician within 7 days post reporting.*Report delivery may be delayed due to unforeseen
circumstances. Inconvenience is regretted.*Certain tests may require further testing at additional cost for derivation of exact value. Kindly submit
request within 72 hours post reporting.*Test results may show interlaboratory variations .*The Courts/Forum at Delhi shall have exclusive
jurisdiction in all disputes/claims concerning the test(s) & or results of test(s).*Test results are not valid for medico legal purposes. * Contact
customer care Tel No. +91-11-39885050 for all queries related to test results.

PatientReportSCSuperPanel.GENERAL_PANEL_ANALYTE_SC (Version: 6)

*134846339* Page 11 of 11